Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Study Identifier
M10-425
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 60 Years
Protocol Summary
The objective of this study is to evaluate the long-term effects and tolerability of ABT-089 in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 8315
Lafayette, California, United States, 94549
Status
Not applicable
Location
Site Reference ID/Investigator# 8306
Jacksonville, Florida, United States, 32216
Status
Not applicable
Location
Site Reference ID/Investigator# 8308
Orlando, Florida, United States, 32806
Status
Not applicable
Location
Site Reference ID/Investigator# 8314
Overland Park, Kansas, United States, 66212
Status
Not applicable
Location
Site Reference ID/Investigator# 8307
Farmington Hills, Michigan, United States, 48336
Status
Not applicable
Location
Site Reference ID/Investigator# 8318
Troy, Michigan, United States, 48085
Status
Not applicable
Showing {first} - {last} of {total} Results